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In animal models of autoimmunity such as in NZB/NZW, and MRL/lpr mice, 
studies from several  laboratories (1) have shown  that spleen cells derived from 
these mice are deficient in the synthesis of IL-2. These observations have been 
extended to human autoimmune diseases; studies by Miyasaka et al. (2), Alcocer- 
Varela et al.  (3) have shown a  deficiency in the synthesis of IL-2 by peripheral 
blood lymphocytes obtained from patients with rheumatoid arthritis and systemic 
lupus  erythematosus.  Thus  the  inability of the  cells of the  immune  system  to 
synthesize  IL-2  may contribute to the  impaired  immunoregulation  and  to the 
pathogenesis of these autoimmune disorders. 
To  determine  the  relationship  of  IL-2  to  autoimmune  diseases,  we  have 
examined  the synthesis  of this  lymphokine in  an  animal  model of rheumatoid 
arthritis.  In  this animal  model,  intraperitoneal  administration  of sonicated  cell 
walls of group A  streptococci induces a  chronic erosive arthritis with histologic 
and radiologic features similar to human rheumatoid arthritis (4, 5). While this 
arthritis can be readily induced in  the Lewis strain,  studies by Wilder et al.  (5) 
have  shown  that  inbred  Fischer  rats  are  resistant  to  the  development  of the 
arthritic  lesions.  Using  these  resistant  and  susceptible  strains,  it  was  therefore 
possible  to  examine  the  relationship  of  IL-2  to  clinical  disease.  This  report 
describes these studies. 
Materials and Methods 
Inbred female Lewis (LEW/N) or Fischer (F344/N) rats (100 g), obtained from Charles 
River  Breeding  Laboratories,  Wilmington,  MA,  were  injected  intraperitoneally  with 
sonicated group A streptococcal cell walls (particle size <0.45 #m) suspended in PBS at a 
dose of 60/~g of cell wall rhamnose per gram body wt (4). Control rats received equivalent 
amounts of PBS.  Rats were routinely observed for the development of clinical  arthritis 
(hind paw inflammation). Hind paw diameters around the ankle joints were measured 
with a vernier caliper. At times indicated, control and cell wall-treated rats were sacrificed, 
and the hind paws  were subjected to radiographic analysis.  The spleens were removed, 
and single-cell suspensions were prepared. These spleen cells (4 ×  105 cells) were cultured 
in microtiter wells for 72 h in 0.2 ml of completely supplemented RPMI-1640 medium 
containing various amounts of Con A.  18 h before harvest, these cultures were pulsed 
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with 1 tzCi of [3H]thymidine, and the amount of cellular radioactivity was determined. All 
of these assays were run in triplicate. 
For assays related to IL-2 synthesis, 5 X  10 6 cells/ml spleen cells were cultured in the 
above medium in the presence of 5 #g/ml of Con A. After 48 h, the medium was harvested 
and the IL-2 content was determined using an IL-2-dependent cell line (CTLL) using the 
procedure of Gillis et al. (6). 
To examine the responsiveness of spleen cells to IL-2, 0.1  ml of spleen cell suspensions 
(4 x  106 cells/ml) derived from control and cell wall-treated rats were cultured for 72 h 
in the presence of IL-2 (100 U/ml) and various amounts of Con A (total volume, 0.2 ml). 
18 h before harvest, the cells were pulsed with [~H]thymidine (1 ~zCi). Cells were harvested 
and assayed for radioactivity. 
To determine the expression of IL-2-R on spleen cells, a mouse mAb (ART-18) directed 
to rat IL-2-R was radiolabeled with z25I as reported (7). Spleen cells from normal and cell 
wall-treated rats (5  x  106 cells/ml) were cultured  for 48  h  in the  presence of Con  A. 
Viable cells were harvested by centrifugation through a discontinuous Ficoll-Paque gra- 
dient (Pharmacia Fine Chemicals Piscataway, NJ).  The ceils were washed with PBS-BSA 
buffer containing 10 mM sodium azide. 1-5 x  106 viable cells in 0.1  ml of PBS-BSA were 
incubated with  1-2 ttg of ~25I-labeled rat anti-IL-2-R antibody. After 60 rain at 4°C,  1 
ml of cold PBS-BSA was added, and the cells were pelleted by centrifugation. The pelleted 
cells were washed with 1 ml of cold PBS-BSA. After centrifugation, the pelleted cells were 
assayed for radioactivity. 
Results 
Confirming earlier  observations of Wilder  et al.  (5),  the  Lewis strain  of rats 
when  treated  with  streptococcal  cell  walls  developed  clinical  arthritis,  whereas 
the Fischer strain of rats were resistant to the development of this lesion (results 
not shown). 
Spleen  cells derived  from either  Lewis or  Fischer  rats that  had been  treated 
with cell walls exhibited a decreased mitogenic response to Con A when compared 
to spleen cells derived from aged-matched control strains (Fig.  1, A and B).  To 
determine  whether  exogenous  IL-2 would  normalize this depressed  mitogenic 
response, spleen cells derived from cell wail-treated Lewis rats were cultured in 
the presence of IL-2 (100  U/ml) and  various concentrations  of Con  A.  Results 
shown in Table I indicate that the addition of exogenous IL-2 did not normalize 
the  mitogenic  response.  These  observations  suggest  that  these  spleen  cells are 
either deficient in the expression of IL-2-R or that IL-2-R are not functional. 
The ability of spleen cells to synthesize IL-2 was also examined. On day 1 after 
cell  wall  treatment,  IL-2  synthesis  by spleen  cells derived  from  Lewis rats  was 
similar to  normal.  However,  with  cell  wall-treated  Fischer  rats,  IL-2 synthesis 
by spleen  cells was significantly  lower than  normals (Table  II). On  days  5,  19, 
and  33  after cell wall  treatment,  spleen  cells from both  Lewis and  Fischer rats 
synthesized decreased amounts of IL-2. 
The deficiency in splenic IL-2 synthesis induced by streptococcal cell walls was 
not  due  to the  toxic effect of the  cell  walls on  the  spleen.  For example, viable 
cell  count  in  the  spleen  of normal  Lewis  rats  was  240  +  22  ×  10 6,  whereas 
spleens of cell wall-treated rats (day 19) contained  168 +  16 X  106 cells. On day 
33, spleens of normal Lewis rats contained 243 4- 16 x  106 cells, whereas spleens 
of cell wall-treated rats contained  168  +  34 ×  10 6 cells. 
To  determine  whether  treatment  of rats  with  cell  walls  depleted  spleens  of 
lymphocytes of a  specific  phenotype,  spleen  cells  from  normal  Lewis  rats  and 
those  treated  with  cell  walls  (day  31)  were  analyzed by flow cytometry (FACS RIDGE  ET  AL. 
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FIGURE  1.  Mitogenic  response  of normal  (4----~)  and  cell  wall-treated  (x .....  x)  Lewis  (A) 
and  Fischer (B) rats. Spleen cells were isolated on day indicated. 
IV;  Becton  Dickinson  Immunocytometry Systems, Mountain View,  CA).  The 
results of this analysis are shown in Table III. The percentage of cells  bearing 
the surface marker W3/25 (helper/inducer subset) was similar in the spleens of 
normal and cell wall-treated rats. In rats, this subset of lymphocytes are respon- 
sible  for  the  synthesis of IL-2.  No  significant differences between  spleens  of 
normal and cell wall-treated rats was detected when the cells were analyzed for 330  RIDGE  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE  I 
Effect of Exogenous IL-2 on Mitogenic Response of Spleen Cells 
Derived from Arthritic Lewis Rats 
[3H]Thymidine incorporation (cpm x  10  -4) 
Con A  Normal  Arthritic  concentration 
(~g/ml)  No additions  Plus IL-2  No additions  Plus 1L-2 
(100 U/mI)  (100 U/ml) 
0  0.5-+0.07  3.5-+0.4  0.1±0  0.05-+0.03 
0.05  11.1-+1.0  14.3-+1.6  0.3-+0.04  0.2  -+0.09 
0.1  22.3±1.2  22.6-+2.1  0.4-+0.08  0.3-+0.2 
0.5  32.4-+2.9  34.3-+3.1  0.5-+0.06  0.4-+0.2 
1.0  40.2-+1.9  44.3-+2.3  0.3-+0,1  0.6-+0.4 
2.0  40.6-+3.5  41.8-+3.6  0.5-+0.3  0.9-+0.7 
Spleen cells from at least five animals were used for each assay on day 33 after cell 
wall treatment. Cultures were incubated for 72 h at 37°C. Other details of the assay 
are described in the text. 
TABLE  II 
IL-2 Synthesis  by Sptenocytes Derived  from Cell Wall-Treated Lewis 
and Fischer Rats 
Days after 
cell wall 
treatment 
IL-2 synthesis (U/ml supernatant) 
Lewis  Fischer 
Normal  Cell wall-treated  Normal  Cell wall-treated 
1  289 -+ 83.4 (6)*  391 -+ 55.6 (6)  199 -+ 32.2 (6)  76 -+ 26.4* (6) 
5  236+52.0(5)  28-+3.0*(5)  146-+41.0(6)  41  -+6.3*(6) 
19  155-+62.1 (7)  23-+ 11.0'(7)  73-+ 14.2(11)  9+3.6'(11) 
33  242-+47.3(9)  34-+ 19.3'(9)  94-+ 13.8(7)  36-+22.3*(7) 
* Values in parentheses represent the number of animals from whom spleen cells were used 
for each assay. 
* p  ~  0.05 as compared to the respective normal group. 
TABLE Ill 
FACS Analysis of Spleen Cells Derived from Normal Lewis Rats and 
Those Treated with Streptococcal Cell Walls 
Percentage of cells staining for: 
Rats 
W3/25  OX-6  OX-8  lgG 
Normal (n =  6)  37-+0.7  35+0.8  17-+0.4  38-+1.1 
Cell wall-treated (n =  5)  37-+3.1  20-+2.0  *  21-+2.7  29--_2.5* 
* FACS analysis performed 31 d  after cell wall treatment, p  _< 0.05 as compared to 
normal rats. Other details of the assay are described in the text. 
OX-8  (suppressor/cytotoxic  subset).  However,  a  significant  decrease  in  cells 
staining for OX-6 (Ia +) and IgG was observed in spleens of cell wall-treated rats. 
These observations indicate that a deficiency in the synthesis of splenic IL-2 after 
cell wall treatment is not due to a depletion of the helper/inducer subset in the 
spleen. 
The conditions for the induction of this IL-2 deficiency were investigated.  In 
results  not  shown,  addition  of various  amounts  of streptococcal  cell  walls  to 
normal  spleen  cells  did  not  inhibit  Con  A-dependent  IL  2  synthesis.  These 
observations  indicate  that  in  vivo  processing  of cell  walls  is  required  for  the 
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TABLE IV 
Binding of Je'~I-labeled Anti-II-2-RmAb to Con A-cultured 
Splenocytes Derived from Normal and Cell Wall-treated Rats 
Rats  Antibody bound (ng/10  ~ cells) 
Normal Fischer  39.7 4- 3.5 
Cell wall-treated Fischer  44.9 4- 5.1 
Normal Lewis  36.7 -+ 0.2 
Cell wall-treated Lewis  37.8 4- 1.5 
Cells were assayed 32 days after cell wall treatment. Spleen cells derived from these 
animals were cultured in Con A, and the binding assays were run in triplicate. Spleen 
cells from at least three animals were used for each assay. Other details are described 
in the text. 
cell  wall-treated  rats  were  deficient in  the  synthesis of IL-2,  several  control 
experiments were conducted. Addition of various amounts of  cell walls to cultures 
of CTLL cells did not inhibit their proliferative response  to IL-2.  Therefore, 
cell walls are not cytotoxic to CTLL cells.  Spent medium from Con A-cultured 
splenocytes derived from cell  wall-treated rats  did not alter the proliferative 
response of CTLL cells  to  IL-2.  Thus the spent medium does not contain an 
inhibitor that can interfere with IL-2 assays. 
To assess the amount of IL-2-R on splenocytes derived from rats treated with 
cell walls,  these cells  and normal splenocytes were cultured in the presence of 
Con A.  Viable cells  were incubated with  lzSI-labeled  rat anti-IL-2-Ria~ntibody. 
Results shown in Table •  IV indicate that splenocytes derived from normal and 
cell wall-treated rats bind equivalent amounts of the labeled antibody. These 
results indicate that the  IL-2-R expression on spleen cells  of cell wall-treated 
rats is similar as in normal cells. 
Discussion 
Recent studies by Miyasaka, et al. (2) have shown a deficiency in the synthesis 
of IL-2 by peripheral blood lymphocytes and synovial mononuclear cells isolated 
from  patients  with  rheumatoid arthritis.  Since  IL-2  plays  a  key  role  in  the 
generation  and  maintenance  of a  normal  immune  response,  a  defect  in  its 
synthesis can contribute to the impaired immunoreguIation observed in rheu- 
matoid arthritis.  Results reported in this communication indicate, for the first 
time, that administration of streptococcal cell walls to rats induces a splenic IL-2 
deficiency. Since this deficiency is  induced in arthritic-susceptible (Lewis) and 
resistant (Fischer) strains, it is likely that immunological abnormalities, in addition 
to IL-2 deficiency, are involved in the development of cell wall arthritis. 
In murine strains of autoimmune disease (1),  IL-2 deficiency is accompanied 
by a  deficiency in  IL-2-R.  Using an  immunological assay, the present  studies 
indicate that, in cell wall-induced arthritis, IL-2-deficient spleen cells appear to 
express normal levels of surface IL-2-R. 
Earlier studies by Hunter, et al. (8) have shown that cell-mediated immunity 
in  rats  with streptococcal cell  wall  arthritis is  impaired.  The  mechanism(s) by 
which  cell  walls  induced  this  deficiency was  not  known.  The  present  studies 
indicate that streptococcal cell walls,  in vivo, induce an IL-2 deficiency and this 
deficiency may, at least in part,  contribute to the impairment in cell-mediated 
responses in these animals. The mechanism(s) by which streptococcal cell walls, 332  RIDGE  ET  AL  BRIEF  DEFINITIVE REPORT 
in  vivo,  induce  an  IL-2  deficiency  has  not  been  established.  However,  the 
observation  that cell  walls induce an  IL-2 deficiency in a  short  time makes this 
animal model  useful  for studies  related  to  immunoregulation.  In addition,  the 
model provides for an assay of potential therapeutic  agents that  may modulate 
IE-2 synthesis. 
Summary 
Intraperitoneal administration of group A streptococcal cell walls to Lewis rats 
induces  a  chronic arthritis,  whereas the  Fischer  strain  is resistant  to  the  devel- 
opment of the lesion. Spleen cells from cell wall-treated rats (Lewis and Fischer) 
are deficient in the synthesis of IL-2. Using an mAb directed against the rat IL- 
2-R, the present studies indicate that the expression of IL-2-R on spleens of cell 
wall-treated rats is normal.  However, the addition  of exogenous IL-2 to spleen 
cells cultured with Con A  does not stimulate the mitogenic response. 
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